开云app官网登录入口网页版-官方正版

#结核病患者#

13篇内容 | 992人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1746226, encodeId=1b1c1e4622624, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=指南推荐《结核病患者接种新型冠状病毒疫苗的专家建议》, objectType=article, longId=293221, objectId=48a329322183, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48a329322183, replyNumber=0, likeNumber=55, createdTime=2022-05-29, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48a329322183, moduleTitle=指南推荐《结核病患者接种新型冠状病毒疫苗的专家建议》, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=48a329322183)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746227, encodeId=eed61e462277c, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=中国防痨杂志：《中国结核病患者关怀手册》专家解读, objectType=article, longId=294436, objectId=8c48294436e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c48294436e7, replyNumber=0, likeNumber=86, createdTime=2022-08-30, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c48294436e7, moduleTitle=中国防痨杂志：《中国结核病患者关怀手册》专家解读, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8c48294436e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746225, encodeId=fbfa1e46225ae, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=Lancet：药物治疗对HIV阳性的多药耐药性结核病患者死亡率的影响, objectType=article, longId=199008, objectId=6966199008bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6966199008bd, replyNumber=0, likeNumber=72, createdTime=2020-08-26, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6966199008bd, moduleTitle=Lancet：药物治疗对HIV阳性的多药耐药性结核病患者死亡率的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6966199008bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746222, encodeId=90461e46222e4, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=LANCET RESP MED：贝达奎宁显著降低耐药结核病患者的死亡率, objectType=article, longId=191131, objectId=01741911314e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01741911314e, replyNumber=0, likeNumber=86, createdTime=2020-11-20, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01741911314e, moduleTitle=LANCET RESP MED：贝达奎宁显著降低耐药结核病患者的死亡率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=01741911314e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746221, encodeId=3e4d1e46221dd, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=含德拉马尼治疗方案在成人和儿童（≥6岁）耐药结核病患者中的“同情用药”, objectType=article, longId=190635, objectId=0f5b19063503, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f5b19063503, replyNumber=0, likeNumber=71, createdTime=2020-10-28, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f5b19063503, moduleTitle=含德拉马尼治疗方案在成人和儿童（≥6岁）耐药结核病患者中的“同情用药”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0f5b19063503)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746224, encodeId=027f1e4622407, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学, objectType=article, longId=192368, objectId=f90c192368f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f90c192368f9, replyNumber=0, likeNumber=59, createdTime=2021-02-04, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f90c192368f9, moduleTitle=Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f90c192368f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746223, encodeId=04ea1e46223ec, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=Clin Infect Dis：接受贝达喹啉或德拉马尼治疗的耐药结核病患者的临床结局, objectType=article, longId=192313, objectId=2b2a192313d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b2a192313d4, replyNumber=0, likeNumber=85, createdTime=2020-05-19, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b2a192313d4, moduleTitle=Clin Infect Dis：接受贝达喹啉或德拉马尼治疗的耐药结核病患者的临床结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2b2a192313d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746219, encodeId=2e5f1e4621939, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=JAMA Intern Med：痰分子检测用于活动性结核病患者病情评估, objectType=article, longId=147581, objectId=d6d014e5815e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6d014e5815e, replyNumber=0, likeNumber=73, createdTime=2019-01-10, rootId=0, userName=木头人525, userId=cf9935672064, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6d014e5815e, moduleTitle=JAMA Intern Med：痰分子检测用于活动性结核病患者病情评估, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d6d014e5815e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746220, encodeId=ca341e462207e, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=PLOS ONE：降脂药的使用与结核病患者结果改善无关：基于人群的队列研究, objectType=article, longId=157965, objectId=6c2315e965cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c2315e965cf, replyNumber=0, likeNumber=72, createdTime=2019-09-11, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c2315e965cf, moduleTitle=PLOS ONE：降脂药的使用与结核病患者结果改善无关：基于人群的队列研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6c2315e965cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746218, encodeId=257b1e462183a, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=Infect Dis：坦桑尼亚城市成人结核病患者具有明显的临床特征和蠕虫混合感染, objectType=article, longId=139509, objectId=753a13950916, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=753a13950916, replyNumber=0, likeNumber=79, createdTime=2019-01-04, rootId=0, userName=木头人525, userId=cf9935672064, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=753a13950916, moduleTitle=Infect Dis：坦桑尼亚城市成人结核病患者具有明显的临床特征和蠕虫混合感染, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=753a13950916)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746217, encodeId=bba41e4621712, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=Pediatrics：儿童结核病患者：传统疗法vs短期方案, objectType=article, longId=132985, objectId=ef3a132985b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef3a132985b3, replyNumber=0, likeNumber=80, createdTime=2019-01-04, rootId=0, userName=木头人525, userId=cf9935672064, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef3a132985b3, moduleTitle=Pediatrics：儿童结核病患者：传统疗法vs短期方案, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ef3a132985b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746216, encodeId=3fd81e46216ba, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=JAMA Intern Med：HIV阳性结核病患者每日抗结核药物治疗方案效果更佳, objectType=article, longId=132175, objectId=88a01321e5e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88a01321e5e9, replyNumber=0, likeNumber=70, createdTime=2018-03-16, rootId=0, userName=木头人525, userId=cf9935672064, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88a01321e5e9, moduleTitle=JAMA Intern Med：HIV阳性结核病患者每日抗结核药物治疗方案效果更佳, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=88a01321e5e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1746215, encodeId=87171e4621572, content=<a href='/topic/show?id=6b49e865466' target=_blank style='color:#2F92EE;'>#结核病患者#</a>, objectTitle=Sci Rep：结核病患者合并糖尿病负担知多少, objectType=article, longId=91655, objectId=418191655bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=418191655bd, replyNumber=0, likeNumber=59, createdTime=2018-02-02, rootId=0, userName=木头人525, userId=cf9935672064, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=418191655bd, moduleTitle=Sci Rep：结核病患者合并糖尿病负担知多少, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=418191655bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

结核病患者

2020-05-29

爆笑小医 (审核中...)

前往app查看评论内容

#结核病患者#

指南推荐《结核病患者接种新型冠状病毒疫苗的专家建议》

2022-05-29

爆笑小医 (审核中...)

前往app查看评论内容

#结核病患者#

中国防痨杂志：《中国结核病患者关怀手册》专家解读

2022-08-30

爆笑小医 (审核中...)

前往app查看评论内容

#结核病患者#

Lancet：药物治疗对HIV阳性的多药耐药性结核病患者死亡率的影响

2020-08-26

爆笑小医 (审核中...)

前往app查看评论内容

#结核病患者#

LANCET RESP MED：贝达奎宁显著降低耐药结核病患者的死亡率

2020-11-20

爆笑小医 (审核中...)

前往app查看评论内容

#结核病患者#

含德拉马尼治疗方案在成人和儿童（≥6岁）耐药结核病患者中的“同情用药”

2020-10-28

爆笑小医 (审核中...)

前往app查看评论内容

#结核病患者#

Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学

2021-02-04

爆笑小医 (审核中...)

前往app查看评论内容

#结核病患者#

Clin Infect Dis：接受贝达喹啉或德拉马尼治疗的耐药结核病患者的临床结局

2020-05-19

木头人525 (审核中...)

前往app查看评论内容

#结核病患者#

JAMA Intern Med：痰分子检测用于活动性结核病患者病情评估

2019-01-10

爆笑小医 (审核中...)

前往app查看评论内容

#结核病患者#

PLOS ONE：降脂药的使用与结核病患者结果改善无关：基于人群的队列研究

2019-09-11

木头人525 (审核中...)

前往app查看评论内容

#结核病患者#

Infect Dis：坦桑尼亚城市成人结核病患者具有明显的临床特征和蠕虫混合感染

2019-01-04

木头人525 (审核中...)

前往app查看评论内容

#结核病患者#

Pediatrics：儿童结核病患者：传统疗法vs短期方案

2019-01-04

木头人525 (审核中...)

前往app查看评论内容

#结核病患者#

JAMA Intern Med：HIV阳性结核病患者每日抗结核药物治疗方案效果更佳

2018-03-16

木头人525 (审核中...)

前往app查看评论内容

#结核病患者#

Sci Rep：结核病患者合并糖尿病负担知多少

2018-02-02

科室
- - 订阅+
  - 更多科室
工具
服务